You are here

  • Home
  • Impact
  • Publications
  • Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib

Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib

Li, B., Shin, H., Glubekyan, G., Pustovalova, O., Nikolsky, Y., Hope, A., ... Schu, M. (2015). Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib. PLoS One.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Chapter

Food acquisition coping strategies used by food insecure adults in New Jersey
Article

The impact of using low-saline oilfield produced water for irrigation on water and soil quality in California
Article

Electrochemical carbon dioxide reduction to isopropanol using novel carbonized copper metal organic framework derived electrodes
Article

Parental Views on Newborn Next Generation Sequencing

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept